Literature DB >> 19570075

Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004.

Anil A Panackal1, Elkan F Halpern, Alice J Watson.   

Abstract

BACKGROUND: Dermatophyte infections lead to high costs and differentially affect certain groups. Previous population studies have been limited in size, duration, and representativeness.
METHODS: Using the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) (1995-2004), a cross-sectional analysis of ambulatory visits in the USA was performed. Outpatients presenting with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)-coded diagnoses of tinea unguium, tinea corporis/manuum, tinea pedis, tinea capitis, and tinea cruris were identified. Trends, descriptive epidemiology, and point prevalence estimates for these conditions were determined using stratification and standardization.
RESULTS: There was an estimated average of 4,124,038 +/- 202,977 annual visits for dermatophytoses during the study period. Tinea unguium, tinea corporis, tinea pedis, tinea capitis, and tinea cruris represented 23.2%, 20.4%, 18.8%, 15.0%, and 8.4%, respectively, of such infections; 71.6% of tinea unguium visits occurred among those older than 45 years. Tinea capitis was significantly more common among the black than the white population (prevalence odds ratio = 12.4; 95% confidence interval, 9.9-15.7). Ineffective treatment of tinea pedis, tinea corporis, and tinea cruris with polyenes, such as nystatin, commonly occurred.
CONCLUSIONS: Improved healthcare provider education is needed to ensure judicious antidermatophyte drug management. Further studies, including proven diagnoses via fungal microscopy and culture, are needed to explain the prevalence discrepancy of tinea capitis among black children and tinea unguium in older adults, focusing on preventable risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570075     DOI: 10.1111/j.1365-4632.2009.04025.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  14 in total

1.  Characterization of Skin Microbiome in Tinea Pedis.

Authors:  Xiaoping Liu; Jingwen Tan; Hong Yang; Zhiqin Gao; Qing Cai; Li Meng; Lianjuan Yang
Journal:  Indian J Microbiol       Date:  2019-07-10       Impact factor: 2.461

2.  VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.

Authors:  E P Garvey; W J Hoekstra; W R Moore; R J Schotzinger; L Long; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

3.  Antithrombotic Utilization Trends after Noncardioembolic Ischemic Stroke or TIA in the Setting of Large Antithrombotic Trials (2002-2009).

Authors:  Amir S Khan; Saqib Chaudhry; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2015-02

4.  Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.

Authors:  Hiroyasu Koga; Yasuko Nanjoh; Hideo Kaneda; Hideyo Yamaguchi; Ryoji Tsuboi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

5.  Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis.

Authors:  Alfonso J Carrillo-Muñoz; Cristina Tur-Tur; Delia C Cárdenes; Dolors Estivill; Gustavo Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

6.  Onychomycosis in underrepresented groups: an all of us database analysis.

Authors:  Isabelle Moseley; Sara D Ragi; Samantha Ouellette; Babar Rao
Journal:  Arch Dermatol Res       Date:  2022-10-19       Impact factor: 3.033

Review 7.  New Antifungal Agents and New Formulations Against Dermatophytes.

Authors:  Aditya K Gupta; Kelly A Foley; Sarah G Versteeg
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

8.  In vitro antifungal activity of naftifine hydrochloride against dermatophytes.

Authors:  M Ghannoum; N Isham; A Verma; S Plaum; A Fleischer; B Hardas
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

9.  Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.

Authors:  Kaitlin Benedict; Brendan R Jackson; Tom Chiller; Karlyn D Beer
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

10.  Prevalence of Tinea capitis in school going children from Mathare, informal settlement in Nairobi, Kenya.

Authors:  Jedidah Ndunge Moto; John Muthini Maingi; Anthony Kebira Nyamache
Journal:  BMC Res Notes       Date:  2015-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.